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lThe Impact of Gender on In-hospital Outcomes after Carotid Endar-
terectomy or Stenting
Bisdas T., Egorova N., Moskowitz A.J., Sosunov E.A., Marin M.L., Faries
P.L., Vouyouka A.G. Eur J Vasc Endovasc Surg 2012;44:244-50.
Aim: We sought to better define the impact of sex on ‘in-hospital
outcomes’ after carotid endarterectomy (CEA) or stenting (CAS).
Methods: Hospital discharge databases for all carotid interventions
obtained from the New York State (NYS) Department of Health, Statewide
Planning and Research Cooperative System between 2000 and 2009
(29,917 women, 39,771 men) were analysed. Mortality, stroke and com-
posite event (stroke/death) were compared between procedures after
matching of patients by propensity score. Acutemyocardial infarction (AMI)
was our secondary ‘end’ point.
Results: More than 90% of patients in both sexes were asymptomatic
(27,439 women and 36,295 men). Compared to men, asymptomatic
women experienced more strokes after CEA (women: 1.38%, men: 1.16%,
P  0.03) and higher AMI rates after both procedures (CEA; women:
0.75%, men: 0.51%, P  0.0009, CAS; women: 0.96%, men: 0.28%,
P  0.01). Between procedures, symptomatic women undergoing CAS
showed higher rates of mortality (CAS: 4.19%, CEA: 0.47%, P  0.01) and
combined (stroke/mortality) events (CAS: 12.09%, CEA: 6.05%,
P  0.02). In all other cohorts, no statistically significant difference was
found between the procedures.
Conclusions: Compared to CEA, CAS led to inferior in-hospital
outcomes only in symptomatic women in the last decade in NYS. Men and
asymptomatic women showed comparable outcomes after both procedures,
whereas asymptomatic females were more prone to AMI after both inter-
ventions. These sex-associated differences should be taken into account for
the treatment of carotid artery disease.
No Benefit from Carotid Intervention in Fatal Stroke Prevention for
>80-Year-old Patients
De Rango P., Lenti M., Simonte G., Cieri E., Giordano G., Caso V., Isernia
G., Cao P. Eur J Vasc Endovasc Surg 2012;44:252-9.
Background: Invasive management of patients 80 years of age with
carotid stenosis may be questionable. The higher likelihood of stroke needs
to be balanced with the increased perioperative risk and the reduced life
expectancy of this ageing population. The purpose of this study was to
evaluate the clinical relevance of carotid stenosis revascularisation in octoge-
narians.
Methods: All patients 80 years of age who received carotid revascu-
larisation in 2001–2010 were reviewed for perioperative and 5-year out-
comes. The experience was comprehensive of carotid endarterectomy
(CEA) and carotid stenting (CAS) performed during the training frame
when age was not a contraindication for this procedure. Mortality rates were
compared to those of octogenarians of the same geographical territory
according to all-cause and stroke-related mortality national statistics data-
sets.
Results:A total of 348 procedures performed in80-year-old patients
(272males) were reviewed: 162 (46.6%) were by CAS and 169 (48.6%) were
for symptomatic disease. Perioperative stroke/death rate was 5.5% and was
non-significantly higher for symptomatic disease (7.1% vs. 3.9% asymptom-
atic; p  0.24), after CAS (6.2% vs. 4.8% CEA; p  0.64) and in females
(6.6% vs. 5.1% males; p  0.57). At median follow-up of 36.18 months, 95
deaths and 21 new ischaemic strokes (12 fatal) occurred with 5-year Kaplan–
Meier freedom from stroke of 84.8% (78.7%, symptomatic vs. 90.3% asymp-
tomatic; p  0.003). According to national datasets, in 80–85-year-old
resident population 5-year mortality was 29.9% (23.4% females, 40.6%
males) and ischaemic stroke-related mortality was 14.9% (16.8% females,
13.0% males). Corresponding figures from treated population showed a
5-year mortality of 49.4%, higher in males (39.5% females, 52.5%males) and
ischaemic stroke-related mortality of 20.2%, higher in females (40.0% fe-
males, 15.6% males). Comparing data from the study population with
residents’ figures, ischaemic stroke-related mortality hazard was significantly
higher in the study females: odds ratio (OR) 3.2, 95% confidence interval
(CI) 1.16–9.17; p  0.029 (for males: OR 0.97, 95%CI 0.89–1.10;
p  0.99).
Conclusions: Despite perioperative stroke/death risks being lower
compared with CAS, the benefit of surgical carotid revascularisation in old
patients remains controversial due to limited life expectancy and high fatality
of stroke in this ageing population. Invasive treatment of carotid stenosis
o
l
878ay not be warranted in most patients 80 years of age with carotid
tenosis, especially when female and asymptomatic.
AA with a Challenging Neck: Early Outcomes Using the Endurant
tent-Graft System
etacci F., Sirignano P., de Donato G., Chisci E., Iacoponi F., Galzerano G.,
alasciano G., Cappelli A., Setacci C. Eur J Vasc Endovasc Surg 2012;44:
74-9.
Objectives: The efficacy and safety of endovascular aneurysm repair is
isputable in aneurysms with a short, angulated, wide, conical, or thrombus-
ined neck making a reliable seal difficult to achieve. The influence of a
hallenging neck on early results using the Endurant stent-graft system in
igh risk patients was investigated.
Matherials and methods: A retrospective study conducted on a
rospectively compiled database of 72 elective patients with challenging
eck treated with the Endurant system (Endurant Stent Graft, Medtronic
VE, Santa Rosa, CA, USA). These patients were compared to a control
roup (n  65) without significant neck problems. Endpoints were early
echnical and clinical success, deployment accuracy and differences in oper-
tive details at onemonth follow-up. Data are reported asmean and standard
eviation or as absolute frequency and percentage (%). Normality distribu-
ion and homogeneity of variances were tested by Shapiro–Wilks and Levene
ests, respectively. Inter-group comparisons for each variable were made by
-test or 2-test or Fisher exact test. A p  0.05 was considered statistically
ignificant.
Results:Mean age was 76.12 years; 76.6% were males. Risk factors and
re-operative variables did not differ significantly between the two groups.
ean neck length was 10.56 mm in patients with challenging anatomies and
2.85 mm in controls. Patients with a challenging neck differed significantly
p  0.001) from controls in terms of mean infrarenal (37.67° vs. 20.12°)
nd suprarenal angle (19.63° vs. 15.57°); 82% of patients with a challenging
eck were ASA III/IV (vs. 86%). Technical success was 100%, with four
nplanned proximal extension in challenging group. No type I endoleaks or
neurysm-related deaths occurred in either group; major complications were
.54% vs. 1.39% (p  0.942). Operative details were similar in both groups.
Conclusion: Treatment with the Endurant stent-graft is technically
easible and safe, yielding satisfactory results even in challenging anatomies.
edium- and long-term data are needed to verify durability, but early results
re promising.
ow Secure is the Anastomosis between the Proximal and Distal Body
omponents of a Fenestrated Stent-Graft?
curr J.R.H., McWilliams R.G., How T.V. Eur J Vasc Endovasc Surg
012;44:281-6.
Objectives: To examine the longitudinal migratory force required to
ause disconnection of the bifurcated distal body component from the
ubular proximal body of a fenestrated stent-graft.
Methods: Using a previously reported mathematical model distal
istraction forces were calculated prior to performing in vitro pullout test-
ng. The top end of the proximal body and the iliac limbs of the distal body
ere attached to the grips of a tensile tester via plastic sealing plugs and
neumatic clamps. Channels within the plugs allowed pressurisation of the
nside of the stent-graft. Pullout tests were conducted in the vertical plane.
orce and displacement data were recorded and tests repeated 8 times at
oom temperature with the stent-grafts either dry or wet and unpressurized,
t 100 mmHg or at 120 mmHg.
Results: The median maximum pullout force was 2.9 N (2.6–4.1)
hen dry, 3.9 N (3.5–5.4) when wet and unpressurized, 6.3 N (4.8–8.3)
hen wet and pressurized at 100 mmHg and 6.5 N (4.8–7.2) when wet and
ressurized at 120 mmHg. There was a significant difference between
ressurized and unpressurized conditions (P  0.01).
Conclusions: The force required to distract the distal bifurcated com-
onent of a fenestrated stent graft is much lower than the reported proximal
xation strength of both a standard and fenestrated Zenith stent graft.
lthough this helps protect the fenestrated proximal body from the effects of
ongitudinal migration forces in vivo the current strength of the body
verlap zone may actually be unnecessarily weak and requires careful surveil-
ance in follow up.
